Literature DB >> 29092962

Multiple endocrine neoplasia type 1 presenting with refractory seizures.

Banshi Lal Kumawat1, Chandramohan Sharma1, Mohit Janakkumar Shah1, Maulik Panchal1.   

Abstract

We report a case of 29-year-old woman referred to us for management of refractory epilepsy. Under observation, she was detected to have recurrent hypoglycaemia during the episodes of seizures. On investigation, she was found to have hyperinsulinemic hypoglycaemia. Her triple-phase CT scan of abdomen showed neuroendocrine tumour of pancreatic head, with bilateral renal calculi. Screening of other endocrine glands revealed pituitary microadenoma and parathyroid adenoma on imaging, which was also supported by biochemical and hormonal profile. On the basis of tumours involving parathyroid, pancreatic islets and pituitary gland, she was diagnosed as a case of multiple endocrine neoplasia type 1. Pancreatic tumour removal was done and bromocriptine was started. She was followed up for 6 months postoperatively and never had seizures even without antiepileptic drugs. This case report highlights an exceptional treatable cause of uncontrolled seizures. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  epilepsy and seizures; neuroendocrinology

Mesh:

Year:  2017        PMID: 29092962      PMCID: PMC5695526          DOI: 10.1136/bcr-2016-218982

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

Authors:  Rajesh V Thakker; Paul J Newey; Gerard V Walls; John Bilezikian; Henning Dralle; Peter R Ebeling; Shlomo Melmed; Akihiro Sakurai; Francesco Tonelli; Maria Luisa Brandi
Journal:  J Clin Endocrinol Metab       Date:  2012-06-20       Impact factor: 5.958

Review 2.  Multiple endocrine neoplasia type 1: clinical and genetic topics.

Authors:  S Marx; A M Spiegel; M C Skarulis; J L Doppman; F S Collins; L A Liotta
Journal:  Ann Intern Med       Date:  1998-09-15       Impact factor: 25.391

3.  Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.

Authors:  S Ellard; A T Hattersley; C M Brewer; B Vaidya
Journal:  Clin Endocrinol (Oxf)       Date:  2005-02       Impact factor: 3.478

4.  Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

Authors:  Maria A Kouvaraki; Jeffrey E Lee; Suzanne E Shapiro; Robert F Gagel; Steven I Sherman; Rena V Sellin; Gilbert J Cote; Douglas B Evans
Journal:  Arch Surg       Date:  2002-06

5.  Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

Authors:  D Trump; B Farren; C Wooding; J T Pang; G M Besser; K D Buchanan; C R Edwards; D A Heath; C E Jackson; S Jansen; K Lips; J P Monson; D O'Halloran; J Sampson; S M Shalet; M H Wheeler; A Zink; R V Thakker
Journal:  QJM       Date:  1996-09

Review 6.  The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1.

Authors:  S E Carty; A K Helm; J A Amico; M R Clarke; T P Foley; C G Watson; J J Mulvihill
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

  6 in total
  1 in total

Review 1.  A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis.

Authors:  Xuefang Hu; Jian Guan; Yangdi Wang; Siya Shi; Chenyu Song; Zi-Ping Li; Shi-Ting Feng; Jie Chen; Yanji Luo
Journal:  Ann Transl Med       Date:  2021-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.